Childhood-onset growth hormone (GH) deficiency in adult life.
Over the last decade GH replacement therapy for adults has progressed in status from research study to a mainstream clinical indication. An area ripe for further research, however, is the difference between adults who developed GHD before and after completion of growth and puberty. That differences exist, not only in aetiology, but also in phenotype and response to GH therapy is clear. However, whether these differences are intrinsic to the timing of onset of GHD, or related to secondary factors including the method of assessment or dose of GH employed is uncertain. This chapter discusses the current state of knowledge in this area and poses further questions, not only for the researcher attempting to understand the mechanisms underlying these differences, but also for the physician seeking to ameliorate the impact of GHD in patients who acquired GHD in childhood.
Lissett
Catherine A
CA
Department of Endocrinology, Christie Hospital, Manchester, UK.
Shalet
Stephen M
SM
D000375:Aging; D001823:Body Composition; D015519:Bone Density; D006128:Growth; D006321:Heart / Q000503:physiopathology; D020249:Hormone Replacement Therapy; D019382:Human Growth Hormone / Q000009:adverse effects / Q000172:deficiency* / Q000627:therapeutic use; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D010641:Phenotype; D010903:Pituitary Gland, Anterior / Q000503:physiopathology; D011627:Puberty; D011788:Quality of Life; D016896:Treatment Outcome
D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I